PERGOVERIS

emd serono, a division of emd inc., canada🇨🇦 Health Canada

Approval Id: 27da461f5fc1ffdf
Drug Approval Canada Name: PERGOVERIS
Product Name: PERGOVERIS
Status: Marketed
Status Date: 2021-10-21
Original Market Date: 2021-10-21
Din: 02470640
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 68:18.00
Atc Original: G03GA30 COMBINATIONS
Atc Name: g 03 ga 30
Aig Number: 0257310002
Company Name: emd serono, a division of emd inc., canada
Company Address: 2695 North Sheridan Way, Suite 200, Mississauga, Ontario, Canada, L5K 2N6

FOLLITROPIN ALFA

300 UNIT / 0.48 ML

LUTROPIN ALFA

150 UNIT / 0.48 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

27da461f5fc1ffdf

Type

Standard